Pricing Log in Create free account

Mangoceuticals, Inc. (MGRX) vs Renalytix plc - Sponsored ADR (RNLXY)

Mangoceuticals, Inc. and Renalytix plc - Sponsored ADR are both Health Information Services companies. Renalytix plc - Sponsored ADR is the larger, with a market value of $17.2M against $4.3M — 4.0× the size. Renalytix plc - Sponsored ADR grew revenue faster over the last twelve months: −18.3% against −38.9%. Renalytix plc - Sponsored ADR has the higher net margin (−1,186.2% vs −4,790.3%) and the higher return on invested capital (0.00% vs −62.8%). Across the 16 metrics below, Renalytix plc - Sponsored ADR leads on 14 and Mangoceuticals, Inc. on 2.

Valuation

Metric MGRX RNLXY Health Information Services median
P/E n/m n/m 40.99
P/S 10.86 3.31 1.83
P/B 0.27 n/m 1.86
Price to free cash flow n/m n/m 19.60
EV/EBITDA n/m n/m 13.36
EV/Sales 10.13 2.68 2.35
Earnings yield (597.60%) (465.34%) (2.65%)
Free cash flow yield (111.74%) (295.15%) 0.00%

Profitability

Metric MGRX RNLXY Health Information Services median
Gross margin 54.42% 14.52% 59.61%
Operating margin (3,915.89%) (1,087.73%) (10.54%)
Net margin (4,790.26%) (1,186.20%) (16.14%)
Free cash flow margin (1,234.03%) 0.00% 0.00%
Return on equity (95.09%) 0.00% (3.15%)
Return on assets (86.27%) 0.00% (5.62%)
Return on invested capital (62.76%) 0.00% 0.00%

Growth

Metric MGRX RNLXY Health Information Services median
Revenue growth (TTM) (38.90%) (18.32%) 6.48%
EPS growth (last fiscal year) 55.17% 75.71% 63.46%
Revenue growth, 5-year CAGR — — 10.98%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric MGRX RNLXY Health Information Services median
Debt to equity 0.00 (5.99) 0.00
Current ratio 0.18 2.43 2.03
Net debt to EBITDA 0.10 (0.26) 0.71

Dividend

Metric MGRX RNLXY Health Information Services median
Dividend yield — — —
Payout ratio — — —

Size

Metric MGRX RNLXY Health Information Services median
Market cap 4.26m 17.18m 294.31m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack